Pune, India -- (SBWire) -- 06/27/2018 --Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled and trained professionals in hospitals & transplant centers, commercial service providers, research laboratories and academic institutes.
Global Transplant Diagnostics Market by Technology (Molecular Assay Technologies (PCR-Based Molecular Assay Technologies (Real-Time PCR, SSP-PCR, SSO-PCR), Sequencing-Based Molecular Assay Technologies (Sanger, NGS)), Non-Molecular Assay Technologies), Product type (Reagents & Consumables, Instruments, Software & Services), Application (Diagnostic, Research), End User (Hospitals & Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) and Forecast to 2024.
Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-transplant-diagnostics-market
Report Drivers and Restraints:
- Rising Incidence of Chronic and Infectious Diseases
- Rising Number of Transplantation Procedures
- Growing Public-Private Investments and Funding
- High costs in performing HLA matching using PCR and NGS devices
- Limited Medical Reimbursements for Transplantation Procedures
Report Segmentation:
By Technology:
- Molecular Assay Technologies
- Sequencing-Based Molecular Assay Technologies
- Non-Molecular Assay Technologies
The Molecular Assay Technologies segment is further sub-segmented into:
- PCR-Based Molecular Assay Technologies
- Sequencing-Based Molecular Assay Technologies
- Non-Molecular Assay Technologies
The PCR-Based Molecular Assay Technologies are further sub-segmented into:
- Real-Time PCR, Sequence-Specific Primer-PCR (SSP-PCR)
- Sequence-Specific Oligonucleotide-PCR (SSO-PCR)
- Other PCR Technologies
The Sequencing-Based Molecular Assay Technologies are further sub-segmented into:
- Sanger Sequencing
- Next-Generation Sequencing (NGS)
- Other Sequencing Technologies
By product type:
- Reagents & Consumables
- Instruments
- Software & Services
On the basis of application:
- Diagnostic
- Research
On the basis of end-users:
- Hospitals & Transplant Centers
- Commercial Service Providers
- Research Laboratories
- Academic Institutes
On the basis of geography:
- North America
- South America
- Europe
- Asia-Pacific
- Middle East & Africa
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Speak to Analyst @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-transplant-diagnostics-market
Competitive Analysis:
The transplant diagnostics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of transplant diagnostics market for global, Europe, North America, Asia Pacific and South America.
Top Key Competitors:
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Limited
- Qiagen N.V.
- Biomérieux SA
- Immucor, Inc.
- Illumina, Inc.
- Becton Dickinson and Company
- Caredx, Inc.
- Gendx
- Sigma-Aldrich Corporation
- Abbott
- DiaSorin S.P.A.
- Affymetrix, Inc.
- Omixon Ltd.
- Olerup SSp AB
- Linkage Biosciences
Frequently Asked Questions:
- What will the market size be in 2024?
- What are the key factors driving the global market?
- What are the challenges to market growth?
- Who are the key players in the market?
- What are the market opportunities and threats faced by the key players?
- What will be the growth rate in 2024?
- Which strategies are used by top players in the Global Transplant Diagnostics Market?
Read more about the Global Transplant Diagnostics Market Visit @ http://databridgemarketresearch.com/reports/global-transplant-diagnostics-market/
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Transplant Diagnostics Market Forecast 2018-2024: Biomérieux SA, Immucor, Inc., Illumina, Inc., Becton Dickinson and Company, Caredx, Inc., Gendx, Sigma-Aldrich Corporation, Abbott
According to a new report published by Data Bridge Market Research “Global Transplant Diagnostics Market”, accounted to USD 2.13 billion in 2016 growing at a CAGR of 9.5% during the forecast period of 2017 to 2024.